HomeCOLL • NASDAQ
add
Collegium Pharmaceutical Inc
Previous close
$46.23
Day range
$46.06 - $47.00
Year range
$23.23 - $48.18
Market cap
1.48B USD
Avg Volume
522.26K
P/E ratio
29.11
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 209.36M | 31.42% |
Operating expense | 121.02M | 46.04% |
Net income | 31.51M | 237.51% |
Net profit margin | 15.05 | 156.83% |
Earnings per share | 2.25 | 39.75% |
EBITDA | 123.18M | 25.99% |
Effective tax rate | 27.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 285.86M | 138.30% |
Total assets | 1.61B | -1.70% |
Total liabilities | 1.33B | -4.88% |
Total equity | 274.81M | — |
Shares outstanding | 31.61M | — |
Price to book | 5.31 | — |
Return on assets | 10.42% | — |
Return on capital | 13.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 31.51M | 237.51% |
Cash from operations | 78.44M | 971.63% |
Cash from investing | -30.87M | 87.60% |
Cash from financing | -14.82M | -109.94% |
Net change in cash | 32.75M | 130.07% |
Free cash flow | 82.88M | -20.68% |
About
Founded
2002
Website
Employees
357
